MALIC ACID
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 132.0 | -3.8 | 1 | 5 | 100.0 | 3 | 0.5 |
- CAS
- 6915157
- UNII
- 817L1N4CKP
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 82 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT02315430 | 2015-04-01 | Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | Phase 2 | Not Yet Recruiting |
| NCT02243605 | 2014-12-01 | Cabozantinib-s-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma | Phase 2 | Recruiting |
| NCT02370030 | 2014-11-01 | Controlled Randomized Multi-centric Clinical Trial on the Effect of Citrulline on the Clinical and Biochemical Evolution of Patients With Sepsis | Phase 1/Phase 2 | Recruiting |
| NCT01917123 | 2013-08-01 | The Effect of L-Citrulline Malate on Ankle Brachial Index Among Patients With Coronary Heart Disease | Phase 0 | Not Yet Recruiting |
| NCT01835158 | 2013-07-01 | Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer | Phase 2 | Recruiting |
| NCT01835145 | 2013-07-01 | Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye | Phase 2 | Suspended |
| NCT01822522 | 2013-06-01 | Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus | Phase 1 | Recruiting |
| NCT01835184 | 2013-05-01 | Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery | Phase 1 | Terminated |
| NCT01866410 | 2013-05-01 | Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer | Phase 2 | Active, Not Recruiting |
| NCT01811212 | 2013-05-01 | Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer | Phase 2 | Recruiting |
| NCT01935934 | 2013-04-01 | Cabozantinib-S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer | Phase 2 | Recruiting |
| NCT01708954 | 2013-02-01 | Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | Phase 2 | Active, Not Recruiting |
| NCT01716715 | 2012-11-01 | Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer | Phase 2 | Active, Not Recruiting |
| NCT01709435 | 2012-11-01 | Cabozantinib in Treating Younger Patients With Recurrent or Refractory Solid Tumors | Phase 1 | Active, Not Recruiting |
| NCT01664182 | 2012-08-01 | Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer | Phase 2 | Recruiting |
| NCT01683981 | 2012-08-01 | Exercise Capacity and Quality of Life in Patients With PPH Receiving Short Term Oral L-Citrulline Malate | Phase 0 | Recruiting |
| NCT01396148 | 2012-06-01 | A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor | Phase 2 | Recruiting |
| NCT01653574 | 2012-05-01 | A Study of Famitinib Malate in HER2-negative Metastatic Breast Cancer | Phase 2 | Completed |
| NCT01462695 | 2012-02-01 | Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma | Phase 2 | Active, Not Recruiting |
| NCT01652001 | 2011-01-01 | Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity | Phase 2/Phase 3 | Recruiting |
| NCT01243359 | 2010-10-01 | Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies | Phase 1 | Completed |
| NCT01210053 | 2010-09-01 | Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | Phase 2 | Recruiting |
| NCT01158222 | 2010-08-01 | Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney Cancer | Phase 2 | Active, Not Recruiting |
| NCT01164202 | 2010-07-01 | Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer | Phase 2/Phase 3 | Recruiting |
| NCT01164228 | 2010-06-01 | Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery | Phase 2 | Recruiting |
| NCT00979992 | 2010-04-01 | Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer | Phase 2 | Active, Not Recruiting |
| NCT01073644 | 2010-02-01 | Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients | Phase 4 | Terminated |
| NCT01061411 | 2010-02-01 | Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic or Unresectable Kidney Cancer | Phase 1 | Active, Not Recruiting |
| NCT00813423 | 2010-01-01 | Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy | Phase 1 | Active, Not Recruiting |
| NCT00890747 | 2009-08-01 | Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy | Phase 1 | Completed |
| NCT00891878 | 2009-08-01 | Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction | Phase 2 | Completed |
| NCT00879619 | 2009-07-01 | Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients | Phase 1/Phase 2 | Terminated |
| NCT01762280 | 2009-06-01 | A Phase I Study of Famitinib Malate in Patients With Solid Tumor | Phase 1 | Active, Not Recruiting |
| NCT00912912 | 2009-05-01 | Sunitinib Malate in Refractory Germ Cell Tumors | Phase 2 | Terminated |
| NCT00910039 | 2009-04-01 | Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases | Phase 2 | Terminated |
| NCT00936832 | 2009-04-01 | Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery | Phase 2 | Withdrawn |
| NCT01089088 | 2009-04-01 | Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium | Phase 2 | Active, Not Recruiting |
| NCT00814021 | 2009-04-01 | Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain | Phase 2 | Completed |
| NCT00931450 | 2009-03-01 | Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer | Phase 1/Phase 2 | Recruiting |
| NCT00859339 | 2009-03-01 | Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC | Phase 2 | Terminated |
| NCT00853125 | 2009-02-01 | Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | Phase 2 | Active, Not Recruiting |
| NCT00953459 | 2009-02-01 | Sunitinib Malate in Treating Patients With Small Cell Lung Cancer | Phase 2 | Terminated |
| NCT00824538 | 2009-02-01 | Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow | Phase 2 | Completed |
| NCT00521092 | 2009-01-01 | Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma | Phase 2 | Withdrawn |
| NCT00792025 | 2008-12-01 | Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer | Phase 2 | Completed |
| NCT01005472 | 2008-12-01 | Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma | Phase 1/Phase 2 | Active, Not Recruiting |
| NCT00793871 | 2008-11-01 | Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor | Phase 4 | Completed |
| NCT01118351 | 2008-10-01 | Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer | Phase 2 | Active, Not Recruiting |
| NCT01529957 | 2008-09-01 | A Study of Nemonoxacin Malate Sodium Chloride Injection Administered by Intravenous Infusion | Phase 1 | Completed |
| NCT00787787 | 2008-09-01 | Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer | Phase 2 | Terminated |
| NCT00753727 | 2008-09-01 | Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma | Phase 1/Phase 2 | Recruiting |
| NCT00748163 | 2008-08-01 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | Phase 2 | Withdrawn |
| NCT00730353 | 2008-08-01 | Sutent + Taxol for Advanced Esophageal Cancer | Phase 2 | Completed |
| NCT00555672 | 2008-08-01 | Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer | Phase 1 | Completed |
| NCT00906360 | 2008-07-01 | Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck | Phase 1 | Terminated |
| NCT00699374 | 2008-07-01 | Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer | Phase 3 | Terminated |
| NCT00706706 | 2008-07-01 | Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma | Phase 4 | Completed |
| NCT00717587 | 2008-06-01 | Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer | Phase 2 | Recruiting |
| NCT00716625 | 2008-06-01 | Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan) | Phase 4 | Active, Not Recruiting |
| NCT00702884 | 2008-06-01 | Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer | Phase 2 | Recruiting |
| NCT00693992 | 2008-06-01 | Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy | Phase 3 | Active, Not Recruiting |
| NCT00555620 | 2008-05-01 | Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer | Phase 1 | Completed |
| NCT00673816 | 2008-05-01 | Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome | Phase 1/Phase 2 | Terminated |
| NCT00716820 | 2008-05-01 | Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan). | Phase 4 | Active, Not Recruiting |
| NCT00698815 | 2008-04-01 | Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | Phase 2 | Active, Not Recruiting |
| NCT00626509 | 2008-02-01 | Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer | Phase 2 | Recruiting |
| NCT00631527 | 2008-02-01 | Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer | Phase 1 | Completed |
| NCT00678431 | 2008-01-01 | Randomized Trial of a Nutritional Supplement in Alzheimer's Disease | Phase 3 | Completed |
| NCT00444795 | 2007-12-01 | Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene | Phase 4 | Enrolling By Invitation |
| NCT00480935 | 2007-10-01 | A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma | Phase 2 | Terminated |
| NCT00526656 | 2007-09-01 | Sunitinib in Treating Patients With Locally Advanced Bladder Cancer | Phase 2 | Completed |
| NCT00514137 | 2007-09-01 | Sunitinib in Treating Patients With Relapsed Multiple Myeloma | Phase 2 | Completed |
| NCT00541008 | 2007-09-01 | Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer | Phase 2 | Recruiting |
| NCT01024205 | 2007-08-01 | Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer | Phase 2 | Completed |
| NCT00375674 | 2007-08-01 | A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer | Phase 3 | Recruiting |
| NCT00398112 | 2007-08-01 | Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | Phase 2 | Completed |
| NCT00514228 | 2007-07-01 | Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | Phase 2 | Completed |
| NCT00519896 | 2007-07-01 | Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer | Phase 2 | Active, Not Recruiting |
| NCT00573404 | 2007-07-01 | Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors | Phase 1 | Terminated |
| NCT00499473 | 2007-06-01 | Sunitinib in Treating Patients With Recurrent Malignant Gliomas | Phase 2 | Active, Not Recruiting |
| NCT00417885 | 2007-06-01 | A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast Cancer | Phase 1/Phase 2 | Terminated |
| NCT00513695 | 2007-06-01 | Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer | Phase 2 | Active, Not Recruiting |
| NCT00428597 | 2007-06-01 | A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors | Phase 3 | Terminated |
| NCT00372567 | 2007-06-01 | Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors | Phase 3 | Terminated |
| NCT00489944 | 2007-05-01 | Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma | Phase 2 | Recruiting |
| NCT00524186 | 2007-05-01 | Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer | Phase 1 | Active, Not Recruiting |
| NCT00499135 | 2007-05-01 | Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors | Phase 1 | Active, Not Recruiting |
| NCT00524316 | 2007-04-01 | Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | Phase 2 | Terminated |
| NCT00482911 | 2007-04-01 | Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma | Phase 2 | Terminated |
| NCT00474994 | 2007-04-01 | Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas | Phase 2 | Completed |
| NCT00478426 | 2007-04-01 | Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer | Phase 2 | Active, Not Recruiting |
| NCT00465179 | 2007-03-01 | Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer | Phase 2 | Completed |
| NCT00606008 | 2007-03-01 | A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma | Phase 2 | Completed |
| NCT00453154 | 2007-03-01 | Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer | Phase 1/Phase 2 | Active, Not Recruiting |
| NCT00462982 | 2007-03-01 | Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma | Phase 2 | Completed |
| NCT00453310 | 2007-03-01 | Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment | Phase 2 | Completed |
| NCT00462553 | 2007-03-01 | Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors | Phase 1 | Completed |
| NCT00459875 | 2007-03-01 | Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer | Phase 2 | Completed |
| NCT00459979 | 2007-03-01 | Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery | Phase 2 | Completed |
| NCT00482755 | 2007-03-01 | Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery | Phase 2 | Completed |
| NCT00392496 | 2007-02-01 | Sunitinib in Treating Patients With Relapsed or Refractory Diffuse or Mediastinal Large B-Cell Lymphoma | Phase 2 | Completed |
| NCT00451048 | 2007-02-01 | Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia | Phase 2 | Completed |
| NCT00444314 | 2007-02-01 | Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma | Phase 2 | Completed |
| NCT00392444 | 2007-02-01 | Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma | Phase 2 | Completed |
| NCT00393939 | 2007-02-01 | Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer | Phase 3 | Completed |
| NCT00388037 | 2007-01-01 | Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | Phase 2 | Completed |
| NCT00389974 | 2007-01-01 | Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery | Phase 2 | Completed |
| NCT00463060 | 2007-01-01 | Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer | Phase 1/Phase 2 | Recruiting |
| NCT00411151 | 2006-12-01 | Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer | Phase 2 | Completed |
| NCT00434109 | 2006-11-01 | Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization | Phase 2 | Completed |
| NCT00397787 | 2006-11-01 | Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine | Phase 2 | Completed |
| NCT00400569 | 2006-11-01 | Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma | Phase 2 | Completed |
| NCT00373113 | 2006-11-01 | A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine | Phase 3 | Terminated |
| NCT00378911 | 2006-10-01 | Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus | Phase 2 | Completed |
| NCT00399152 | 2006-10-01 | Perifosine + Sunitinib Malate for Patients With Advanced Cancers | Phase 1 | Completed |
| NCT00387920 | 2006-10-01 | Sunitinib in Treating Young Patients With Refractory Solid Tumors | Phase 1 | Completed |
| NCT00495625 | 2006-10-01 | Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC) | Phase 2 | Terminated |
| NCT00387426 | 2006-09-01 | Sunitinib in Treating Patients With Idiopathic Myelofibrosis | Phase 2 | Terminated |
| NCT00397488 | 2006-09-01 | Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium | Phase 2 | Completed |
| NCT00338884 | 2006-09-01 | Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney Cancer | Phase 2 | Completed |
| NCT00381641 | 2006-08-01 | Sunitinib in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery | Phase 2 | Active, Not Recruiting |
| NCT00425386 | 2006-08-01 | Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer | Phase 2 | Completed |
| NCT00387335 | 2006-08-01 | Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer | Phase 2 | Completed |
| NCT01118039 | 2006-07-01 | Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer | Phase 2 | Recruiting |
| NCT00672594 | 2006-07-01 | Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy | Phase 2 | Completed |
| NCT00357318 | 2006-06-01 | Bevacizumab and Sunitinib in Treating Patients With Solid Tumors | Phase 1 | Completed |
| NCT00329043 | 2006-05-01 | Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy | Phase 2 | Active, Not Recruiting |
| NCT00326898 | 2006-04-01 | Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery | Phase 3 | Active, Not Recruiting |
| NCT00616122 | 2006-03-01 | Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer | Phase 1/Phase 2 | Completed |
| NCT00402415 | 2006-02-01 | Study of Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors Non-Curable With Standard Therapy | Phase 1 | Terminated |
| NCT00267748 | 2005-12-01 | Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC) | Phase 2 | Completed |
| NCT00257010 | 2005-12-01 | A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches | Phase 3 | Completed |
| NCT00273884 | 2005-08-01 | Amonafide in Combination With Cytarabine in Secondary AML | Phase 2 | Completed |
| NCT00210496 | 2005-06-01 | Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine | Phase 4 | Completed |
| NCT00457743 | 2005-01-01 | A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST) | Phase 1/Phase 2 | Completed |
| NCT00210509 | 2004-11-01 | A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache | Phase 4 | Completed |
| NCT00212823 | 2004-06-01 | The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine Pain | Phase 4 | Completed |
| NCT00087854 | 2004-03-01 | Study of Individualized Amonafide to Treat Prostate Cancer | Phase 1/Phase 2 | Completed |
| NCT00210483 | 2003-07-01 | A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents | Phase 3 | Completed |